118 related articles for article (PubMed ID: 22070752)
1. Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies.
Li N; Zhuang CY; Wang M; Sui CG; Pan WS
Drug Deliv; 2012 Jan; 19(1):28-35. PubMed ID: 22070752
[TBL] [Abstract][Full Text] [Related]
2. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
Li N; Zhuang C; Wang M; Sun X; Nie S; Pan W
Int J Pharm; 2009 Sep; 379(1):131-8. PubMed ID: 19559775
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
[TBL] [Abstract][Full Text] [Related]
4. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-coated liposomes for delivery to lungs by nebulisation.
Zaru M; Manca ML; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
[TBL] [Abstract][Full Text] [Related]
6. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.
Kowapradit J; Apirakaramwong A; Ngawhirunpat T; Rojanarata T; Sajomsang W; Opanasopit P
Eur J Pharm Sci; 2012 Sep; 47(2):359-66. PubMed ID: 22771544
[TBL] [Abstract][Full Text] [Related]
7. In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants.
Madrigal-Carballo S; Vila AO; Sibaja M; Reed JD; Molina F
J Liposome Res; 2010 Mar; 20(1):1-8. PubMed ID: 19514859
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
Enríquez de Salamanca A; Diebold Y; Calonge M; García-Vazquez C; Callejo S; Vila A; Alonso MJ
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1416-25. PubMed ID: 16565375
[TBL] [Abstract][Full Text] [Related]
10. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
Amin M; Jaafari MR; Tafaghodi M
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):225-9. PubMed ID: 19699067
[TBL] [Abstract][Full Text] [Related]
11. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Diebold Y; Jarrín M; Sáez V; Carvalho EL; Orea M; Calonge M; Seijo B; Alonso MJ
Biomaterials; 2007 Mar; 28(8):1553-64. PubMed ID: 17169422
[TBL] [Abstract][Full Text] [Related]
12. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
14. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
Werle M; Takeuchi H
Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers.
Wang S; Zhang J; Jiang T; Zheng L; Wang Z; Zhang J; Yu P
Int J Pharm; 2011 Jan; 403(1-2):219-29. PubMed ID: 20971176
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery.
Addo RT; Yeboah KG; Siwale RC; Siddig A; Jones A; Ubale RV; Akande J; Nettey H; Patel NJ; Addo E; D'Souza MJ
J Pharm Sci; 2015 May; 104(5):1677-90. PubMed ID: 25652269
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
Luo Q; Zhao J; Zhang X; Pan W
Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778
[TBL] [Abstract][Full Text] [Related]
19. Development of chitosan-coated liposomes for sustained delivery of tamarind fruit pulp's extract to the skin.
Phetdee M; Polnok A; Viyoch J
Int J Cosmet Sci; 2008 Aug; 30(4):285-95. PubMed ID: 18713075
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
